IRIS Accounts Production v24.3.2.46 01606565 Board of Directors 1.4.23 31.3.24 31.3.24 false true false false true false Fair value model iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh016065652023-03-31016065652024-03-31016065652023-04-012024-03-31016065652022-03-31016065652022-04-012023-03-31016065652023-03-3101606565ns15:EnglandWales2023-04-012024-03-3101606565ns14:PoundSterling2023-04-012024-03-3101606565ns10:Director12023-04-012024-03-3101606565ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3101606565ns10:SmallEntities2023-04-012024-03-3101606565ns10:AuditExempt-NoAccountantsReport2023-04-012024-03-3101606565ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3101606565ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3101606565ns10:AbridgedAccounts2023-04-012024-03-3101606565ns10:Director22023-04-012024-03-3101606565ns10:CompanySecretary12023-04-012024-03-3101606565ns10:RegisteredOffice2023-04-012024-03-3101606565ns5:CurrentFinancialInstruments2024-03-3101606565ns5:CurrentFinancialInstruments2023-03-3101606565ns5:Non-currentFinancialInstruments2024-03-3101606565ns5:Non-currentFinancialInstruments2023-03-3101606565ns5:ShareCapital2024-03-3101606565ns5:ShareCapital2023-03-3101606565ns5:FurtherSpecificReserve3ComponentTotalEquity2024-03-3101606565ns5:FurtherSpecificReserve3ComponentTotalEquity2023-03-3101606565ns5:RetainedEarningsAccumulatedLosses2024-03-3101606565ns5:RetainedEarningsAccumulatedLosses2023-03-3101606565ns5:FurnitureFittings2023-04-012024-03-3101606565ns5:Non-currentFinancialInstruments2023-04-012024-03-3101606565ns5:FurtherSpecificReserve3ComponentTotalEquity2023-03-31
REGISTERED NUMBER: 01606565 (England and Wales)















BABA MEDICAL LIMITED

ABRIDGED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2024






BABA MEDICAL LIMITED (REGISTERED NUMBER: 01606565)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024




Page

Company Information 1

Abridged Balance Sheet 2

Notes to the Financial Statements 4


BABA MEDICAL LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2024







DIRECTORS: Mr K RAJA
Mrs R D RAJA





SECRETARY: Mrs R D Raja





REGISTERED OFFICE: Unit 6
Tariff Road
LONDON
N17 0EB





REGISTERED NUMBER: 01606565 (England and Wales)






BABA MEDICAL LIMITED (REGISTERED NUMBER: 01606565)

ABRIDGED BALANCE SHEET
31 MARCH 2024

31.3.24 31.3.23
Notes £    £   
FIXED ASSETS
Tangible assets 4 104 130
Investment properties 5 2,602,542 2,600,000
2,602,646 2,600,130

CURRENT ASSETS
Debtors 1,349,251 1,110,535
Cash at bank 31,082 26,438
1,380,333 1,136,973
CREDITORS
Amounts falling due within one year (182,555 ) (141,306 )
NET CURRENT ASSETS 1,197,778 995,667
TOTAL ASSETS LESS CURRENT
LIABILITIES

3,800,424

3,595,797

CREDITORS
Amounts falling due after more than one
year

6

(1,200,000

)

(967,690

)

PROVISIONS FOR LIABILITIES (154,300 ) (154,300 )
NET ASSETS 2,446,124 2,473,807

CAPITAL AND RESERVES
Called up share capital 10,000 10,000
Fair value reserve 7 935,525 935,525
Retained earnings 1,500,599 1,528,282
SHAREHOLDERS' FUNDS 2,446,124 2,473,807

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

BABA MEDICAL LIMITED (REGISTERED NUMBER: 01606565)

ABRIDGED BALANCE SHEET - continued
31 MARCH 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Income Statement and an abridged Balance Sheet for the year ended 31 March 2024 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 24 March 2025 and were signed on its behalf by:





Mr K RAJA - Director


BABA MEDICAL LIMITED (REGISTERED NUMBER: 01606565)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

1. STATUTORY INFORMATION

BABA MEDICAL LIMITED is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Income
Income represents rent receivable.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.
Fixtures & Equipment - 20% on reducing balance

Investment property
Investment properties are shown at most recent valuation. Any aggregate surplus or deficit arising from changes in fair value is recognised in the income statement and is ultimately shown in the fair value reserve. No depreciation is provided on investment properties.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2023 - 2 ) .

BABA MEDICAL LIMITED (REGISTERED NUMBER: 01606565)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2024

4. TANGIBLE FIXED ASSETS
Totals
£   
COST
At 1 April 2023
and 31 March 2024 1,959
DEPRECIATION
At 1 April 2023 1,829
Charge for year 26
At 31 March 2024 1,855
NET BOOK VALUE
At 31 March 2024 104
At 31 March 2023 130

5. INVESTMENT PROPERTIES
Total
£   
FAIR VALUE
At 1 April 2023 2,600,000
Additions 2,542
At 31 March 2024 2,602,542
NET BOOK VALUE
At 31 March 2024 2,602,542
At 31 March 2023 2,600,000

Fair value at 31 March 2024 is represented by:
£   
Valuation in 2017 744,057
Valuation in 2023 345,768
Cost 1,512,717
2,602,542

Investment properties are stated at fair values at the date of the balance sheet in the opinion of the directors based on professional valuations carried out in 2022.

6. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN FIVE
YEARS
31.3.24 31.3.23
£    £   
Repayable otherwise than by instalments
Bank loans over 5 years 1,200,000 -

Bank loans are secured by first legal charges on the freehold properties of the company.

BABA MEDICAL LIMITED (REGISTERED NUMBER: 01606565)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2024

7. RESERVES
Fair
value
reserve
£   
At 1 April 2023
and 31 March 2024 935,525

8. RELATED PARTY DISCLOSURES

Amount due from related company is from Nikura Limited in which Mr K Raja is a director and shareholder.